Six-Drug attack on tough blood cancers shows promise
NCT ID NCT03136146
Summary
This study is testing a combination of six chemotherapy drugs for people whose acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma has come back or hasn't responded to previous treatments. The goal is to see if this intensive combination is safe and can effectively control these aggressive cancers. The trial will enroll about 42 patients aged 15 and older to measure how well the treatment works and how long the benefits last.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.